Latinx Investments
347 posts

Latinx Investments
@InvestorLatin
Tech $ZETA $AMZN Finance $DLO Pharma/Biotech $AQST $ABEO $HROW $OCUL $RNAC


$ZETA — Pullback isn’t over ⚠️ Price is now testing the 50WMA. Losing this level signals bears are in control. I still expect a test of the 200WMA, that’s where I load the boat. Wave 3 target: +138% 🚀




Wondering how this dude is doing right now. They never learn. $ADMA

$ADMA Monthly Log. This one is going to correct hard. Extreme overbought. I would be a buyer between $7-$10.




$ASTS — Eyes on this 👀 Price continues to reject the 50DMA. This level needs to be reclaimed before I add. Wave 5 target: +56% 🚀



Summary graphic of atopic dermatitis drugs/targets by benefit/treatment profile: SOC benchmarks: #Dupilumab $SNY $REGN and #Upadacitinib $ABBV Compare to: Injectables in Ph2b trials #APG777 $APGE #Rezpeg $NKTR Oral drugs in Ph2b trials #soquelitinib $CRVS KT-621 $KYMR




11) It gets worse... $ADMA appears to distribute ASCENIV via Genesis BioPharma Services ("Gen Bio"), an IVIG distributor controlled by Vice Chairman Jerrold Grossman (father of CEO Adam Grossman) operating from ADMA's own HQ. $ADMA has never disclosed any RPTs with Gen Bio.





$ZETA — Expect a new low 👀 Price is now below the 200DMA. A rejection here confirms a move to the 200WMA in the $13s. Support there and I’m loading the boat. Wave 3 target: +138% 🚀















